FREE TOOL · NO ACCOUNT NEEDED · LIVE TICKER DATA
R&D Spending History Chart
Chart any stock's 10-year research and development spending in one view, with an R&D-to-revenue ratio overlay and an investment intensity verdict. Auto-populates from Yahoo Finance. Pair it with the operating income history chart and the CapEx history chart.
How to Read the R&D Spending Trend
Research and development expenses are the cash a company spends on creating new products, improving existing ones, or conducting scientific inquiry that it hopes will translate into future revenue. For technology, pharmaceutical, and semiconductor companies, R&D is the primary driver of competitive advantage — the engine of the moat. For retailers, banks, or consumer staples, it is often minimal or not separately reported at all.
Reading R&D in absolute dollars can mislead. A $3B R&D budget is enormous for a mid-cap software firm and unremarkable for a major pharma company. That is why this chart overlays the R&D-to-Revenue ratio, which normalizes investment against the size of the business. Bars are green when R&D grew year-over-year, gray when flat, and red when spending declined — a potential signal of cost-cutting or strategic de-emphasis of research.
R&D is expensed immediately under GAAP, so heavy investment compresses reported earnings even as it builds future value. Reading R&D trends alongside the operating income history chart shows whether margin compression is explained by investment rather than operational inefficiency. Pairing with the ROIC guide reveals whether prior R&D cycles actually generated returns.
Related Tools
Complete the innovation and cost picture with these related tools:
- Operating Income History Chart — see how R&D investment affects operating profit over time
- CapEx History Chart — the other major reinvestment line, for hard assets
- ROIC Guide — whether past R&D investment actually generated returns on capital
- Gross Profit History Chart — the revenue base from which R&D is funded
- SG&A History Chart — operating overhead alongside R&D in the P&L
Frequently Asked Questions
What does the R&D spending history chart show?
It plots up to 10 fiscal years of a company's annual research and development expenses as bars, with R&D as a percentage of revenue overlaid as a line. Together they show both the absolute scale of a company's innovation investment and how committed the business is to R&D relative to its size.
What do the bar colors mean?
Bars are colored by year-over-year change in absolute R&D spending. Green means R&D grew more than 5% YoY — the company is increasing its innovation investment. Gray means spending was roughly flat (within 5%). Red means R&D declined more than 5%, which may signal cost-cutting or a strategic pivot away from research.
What is the R&D intensity verdict?
R&D intensity is R&D spending as a percentage of revenue, averaged across the period shown. 'Investing Heavily' means R&D averages more than 15% of revenue — typical of biotech, semiconductors, and enterprise software. 'Investing' is 5-15%, typical for most technology companies. 'Minimal R&D' is below 5%, common in retail, consumer staples, or industrials where R&D is not the competitive edge.
Why does this show 'Not Reported' for some companies?
Not all companies are required to separately disclose R&D on their income statement. Banks, retailers, utilities, and many industrials bundle innovation costs into other line items or simply have no formal R&D program. When researchDevelopment is not in the reported financials, the chart shows the 'Not Reported' message instead of crashing or showing misleading zeros.
How does R&D relate to a company's competitive moat?
Sustained high R&D spending can build durable competitive advantages — proprietary technology, drug pipelines, or platform ecosystems that are expensive for competitors to replicate. But R&D is an expense before it becomes an asset, so a rising R&D ratio compresses margins in the near term. Reading R&D trends alongside operating income and ROIC shows whether the investment is actually generating returns.
FINISHED THE NUMBERS?
A chart gives you the trend. The report gives you the argument.
Assumptions, scenarios, and what breaks them — on any public company.
See a sample report →